Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 13. mars 2024 kl. 14:57 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Harald Gurvin | – | Kjøp | 14 | 13,99 NOK | 13. mars 2024 | NO0010714785 | XOSL - Oslo Stock Exchange |
Vedlegg
- Attachment 240313.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, March 13, 2024 - Primary insider Harald Gurvin, Chief Financial Officer of Nykode Therapeutics ASA, has today acquired 10,000 shares in Nykode Therapeutics ASA at an average price of NOK 14.00 per share. Following the transaction, Harald Gurvin holds 30,000 shares in Nykode Therapeutics ASA.
Please see further details in the attached document.